A Phase 4 interventional study of NWPT group in Transplant Complication, Renal Transplant and Wound Complication, sponsored by Centro Hospitalar De São João, E.P.E.. Recruiting at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-15.
Sponsored by Centro Hospitalar De São João, E.P.E. · Phase 4, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a prospective study involving patients undergoing open renal transplant. Renal transplant recipients were randomly divided into two groups: the NPWT group, which received NPWT, and the Standard group, which received standard wound dressings.
This is a prospective study involving patients undergoing open renal transplant between January 2023 and August 2024. Pediatric patients, those requiring surgical reinterventions within the first 3 postoperative months, and patients allergic to NPWT components were excluded from the study. Renal transplant recipients were randomly divided into two groups: the NPWT group, which received NPWT, and the Standard group, which received standard wound dressings. NPWT (PICO by Smith \& Nephew) was applied intraoperatively at 80 mmHg and maintained for 7 days. Wound evaluations were performed at 7, 14, 30, and 90 days post-operatively. If dehiscence was present, it was classified as either deep or superficial based on the involvement of the aponeurosis. Patients were assessed for wound infection using the ASEPSIS score, pain with a visual analogue scale, and quality of life using the EQ-5D questionnaire. Scar healing was also evaluated at 30 and 90 days post-operatively with the POSAS score
Centro Hospitalar De São João, E.P.E. is the lead sponsor of 12 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who received negative pressure wound therapy
Device: NWPT group
Patients who received standard dressing
Patients submitted to negative pressure wound therapy
Wound dehiscence
Wound dehiscence - superficial or deep
Time frame: First 90 days after surgery
Wound infection
ASEPSIS score - (Additional treatment, Serous discharge, Erythema, Purulen exudates, Separation of deep tissues, Isolation of bacteria, Stay in hospital score); 0-10 points; higher score = worse outcome
Time frame: First 90 days after surgery
Pain associated with incision
Visual analogue scale; score 0-10; higher score=worse outcome
Time frame: First 90 days after surgery
Quality of life associated with incision
EQ-5D questionnaire (The 5-level quality of life version 5); score 0 -100 ; highest score=better outcome
Time frame: First 90 days after surgery
Scar healing
POSAS score (The Patient and Observer Scar Assessment Scale); score 1-10; highest score=worse outcome
Time frame: First 90 days after surgery
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided — IPD will be shared upon reasonable request after consideration from local Ethics Comission
Started Jan 2023 (actual). Primary completion is estimated for May 2026, 40 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centro Hospitalar De São João, E.P.E.